Skip to main content

Table 1 Baseline characteristics of the patients

From: Validation and modification of existing mortality prediction models for lower gastrointestinal bleeding: a retrospective study

Parameters Results
Sex (%) Male: 627 (57.3) Female: 468 (42.7)
Age, median (range) 68 (19–94)
Comorbidity (%) Cancer 206 (18.8)
Heart failure 131 (12.0)
Renal failure 136 (12.4)
Chronic pulmonary obstructive disease 32 (2.9)
Liver cirrhosis 118 (10.8)
ASA score 1 645 (58.9)
2 152 (13.8)
3 298 (27.2)
Mental status Alert 1045 (95.4)
Altered 50 (4.5)
Medication (%) Antiplatelet 206 (18.8)
Anticoagulant 122 (11.1)
Non-steroidal anti-inflammatory drugs 306 (27.9)
Hospitalization Day, median (range) 6.00 (1–203)
Intensive care unit  
n (%) 51 (4.65)
Day, median (range) 3.00 (1–26)
Mortality (%) All-cause mortality 40 (3.7)
Bleeding-related mortality 23 (2.1)
Non-bleeding-related mortality 17 (1.6)
  1. ASA, American Society of Anesthesiologists